Cellics Therapeutics, Inc.
Cellics Therapeutics is a company focused on developing novel therapeutics to address complex biology related to inflammation and immunology. Their mission is to create innovative solutions for significant unmet medical needs in these areas.
Industries
biotechnology
health-care
therapeutics
Nr. of Employees
small (1-50)
Cellics Therapeutics, Inc.
San Diego, California, United States, North America
Products
CTI-005
A Red Blood Cell Nanosponge designed to treat Methicillin-resistant Staphylococcus Aureus (MRSA) pneumonia by absorbing and neutralizing bacterial toxins.
CTI-111
A Macrophage Nanosponge aimed at treating sepsis by absorbing and neutralizing inflammatory cytokines to control inflammation.
Cellular Nanosponges
Nanoparticles coated with cell membranes to bind and neutralize harmful agents like bacterial toxins, cytokines, and viruses.
CTI-005
A Red Blood Cell Nanosponge designed to treat Methicillin-resistant Staphylococcus Aureus (MRSA) pneumonia by absorbing and neutralizing bacterial toxins.
CTI-111
A Macrophage Nanosponge aimed at treating sepsis by absorbing and neutralizing inflammatory cytokines to control inflammation.
Cellular Nanosponges
Nanoparticles coated with cell membranes to bind and neutralize harmful agents like bacterial toxins, cytokines, and viruses.
Expertise Areas
- Inflammation biology
- Immunology therapeutics
- Therapeutic platform development
- Early-stage biotech development
Key Technologies
- Therapeutics platform
- Platform-based drug discovery
- Immunology-focused therapeutic discovery